Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 335
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06572293 | Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma | ||
| NCT05044871 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT06995118 | The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction | ||
| NCT02979691 | Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 | ||
| NCT06151080 | Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL | ||
| NCT05420480 | Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy | ||
| NCT06333769 | Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer | ||
| NCT03273920 | Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer | ||
| NCT05892354 | Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy | ||
| NCT03720873 | EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC | ||
| NCT05597527 | Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer | ||
| NCT07013461 | International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer | ||
| NCT03641820 | Cognitive Dysfunction in Patients With Cancer Pain | ||
| NCT02845986 | Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer | ||
| NCT04155671 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | ||
| NCT03872635 | Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period | ||
| NCT06140589 | Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer | ||
| NCT06802835 | EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma | ||
| NCT06197126 | MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy | ||
| NCT07541521 | RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC | ||
| NCT03380689 | Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer | ||
| NCT03788174 | Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma | ||
| NCT04923802 | Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION) | ||
| NCT05663177 | Almonertinib Plus Metronomic Oral Vinorelbine | ||
| NCT06788171 | PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM | ||
| NCT04844645 | Using Mini Program for Self-management VS Conventional Pharmaceutical Care for Cancer Pain | ||
| NCT05594095 | SNF Platform Study of HR+/ HER2-advanced Breast Cancer | ||
| NCT06743867 | The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma | ||
| NCT05319639 | Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | ||
| NCT03486509 | Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma | ||
| NCT01337037 | Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC) | ||
| NCT05730595 | Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer | ||
| NCT05753826 | Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. | ||
| NCT05759546 | PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer | ||
| NCT05543070 | Low-dose Radiotherapy in iNHL | ||
| NCT07686796 | Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial | ||
| NCT05649618 | TIL Cells for the Treatment of the Advanced Solid Tumors Patients | ||
| NCT05922358 | Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors | ||
| NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | ||
| NCT07902648 | Serplulimab, DOS and Lenvatinib Combine With PIPAC in the Oligometastatic Peritoneal Metastasis of Gastric/Gastroesophageal Junction Adenocarcinoma | ||
| NCT06035250 | AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy | ||
| NCT07104877 | A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors | ||
| NCT04880746 | Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study | ||
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | ||
| NCT07088484 | Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma | ||
| NCT03222089 | Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC | ||
| NCT07101159 | Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients | ||
| NCT07070713 | Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC | ||
| NCT06197438 | Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer | ||
| NCT06510660 | Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC |
